Dacarbazine (APP Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Dacarbazine drug offered from APP Pharmaceuticals, LLC. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | APP Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | DACARBAZINE |
SUBSTANCE NAME: | DACARBAZINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2001-09-07 |
END MARKETING DATE: | 0000-00-00 |
Dacarbazine HUMAN PRESCRIPTION DRUG Details:
Item Description | Dacarbazine from APP Pharmaceuticals, LLC |
LABELER NAME: | APP Pharmaceuticals, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2001-09-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-127_cee49be4-a9e3-4f9f-852e-a3d3b25ac44f |
PRODUCT NDC: | 63323-127 |
APPLICATION NUMBER: | ANDA075371 |
Other DACARBAZINE Pharmaceutical Manufacturers / Labelers: